4//SEC Filing
Beaulieu Joseph 4
Accession 0000899243-21-033404
CIK 0001571498other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 8:07 AM ET
Size
7.5 KB
Accession
0000899243-21-033404
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Beaulieu Joseph
Corporate Controller
Transactions
- Award
Common Stock, par value $0.0001
2021-08-16+14,833→ 28,264 total - Award
Stock Option (Right to Buy)
2021-08-16+22,250→ 22,250 totalExercise: $5.31Exp: 2031-08-15→ Common Stock (22,250 underlying)
Footnotes (2)
- [F1]Consists of shares of Common Stock issuable under 14,833 restricted stock units ("RSUs") granted pursuant to the Company's 2013 Stock Incentive Plan. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in two equal annual installments over two years from the grant date, with the first installment vesting on August 16, 2022.
- [F2]This option was granted on August 16, 2021 pursuant to the Company's 2013 Stock Incentive Plan with respect to 22,250 shares of Common Stock, with 50% vesting on August 16, 2022 and the remaining 50% vesting on August 16, 2023.
Documents
Issuer
Epizyme, Inc.
CIK 0001571498
Entity typeother
Related Parties
1- filerCIK 0001766032
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 8:07 AM ET
- Size
- 7.5 KB